FDA OKs Dust Mite Allergy Drug for Young Kids
MedPage Today) — The FDA expanded the approval of a sublingual immunotherapy (SLIT; Odactra) for treating house dust mite allergies in young children, drugmaker ALK announced. Taken as a once-daily tablet, the SLIT product is now indicated for…
MedPage Today) — The FDA expanded the approval of a sublingual immunotherapy (SLIT; Odactra) for treating house dust mite allergies in young children, drugmaker ALK announced.
Taken as a once-daily tablet, the SLIT product is now indicated for…
Read More
About Author
